عنوان مقاله [English]
نویسندگان [English]چکیده [English]
Holmium-loaded AcAc nanoparticles are potential agents for radionuclides endoradiotherapy because of their low density, biodegradability and favorable radiation characteristics. In this study, production, quality control and biodistribution studies of 166Ho-AcAc nanoparticles have been presented. Firstly, the stable 165Ho acetylacetonate (AcAc) spheres were prepared by the solvent evaporation technique. The 165Ho-AcAc nanoparticles were converted to the 166Ho-AcAc by irradiation in the Tehran Research Reactor. The morphology, stability, and structural parameters of the complex were investigated by SEM, ITLC, IR and XRD, respectively. The complex solutions (100 μCi/100 μl) were injected intra-tail into rat followed by scarification studies post- injection. The results indicated that the 166Ho-AcAc nanoparticles were prepared successfully with an optimal mean particle size of 70-100 nm and displayed a smooth surface with a high radiochemical purity of more than 97%. The complex was stable at 4ºC, human serum, PBS buffer, and room temperature. The most upper %ID/g of the 166Ho-AcAc nanoparticles was observed in the liver. Our data showed that the AcAc nanoparticles could be made in the optimal size range for the laser irradiation, and their ability to retain 166Ho makes them attractive agents for endoradiotherapy.
1. M. T.Gann, H.C. Chin,E.W Hisn, Cancer Nanotargeted Radiopharmaceuticals for Tumor Imaging and Therapy, Anticancer. Res. 29, 4107 (2009).
2. J. Anthony, et al. Neutron-Activatable Holmium-Containing Mesoporous Silica Nanoparticles as a Potential Radionuclide Therapeutic Agent for Ovarian Cancer, J. Nucl. Med. 54(1), 111-117 (2013).
3. M. Tashiro, Nano-bio-imaging with Radiopharmaceuticals and its Application to Health Sciences, Annal. Nano- BME. 3, 73 (2010).
4. M.E. Davis, Z.G. Chen, D.M. Shin, Nanoparticle therapeutics: an emerging treatment modality for cancer, Nat. Rev. Drug. Discov. 7, 771 (2008).
5. M. Ferrari, Cancer nanotechnology: opportunities and challenges, Nat. Rev. Cancer. 5, 161 (2005).
7. R.C. Bhattacharjee, K.M. Chaudhuri, New Development in the chemistry of metal acetylacetone complexes. Proc. Indian. Natn. Sci. Acad. 55(2), 194 (1989).
8. S.H. Sun, et al, Monodisperse MFe2O4(M = Fe, Co, Mn) nanoparticles, J. Am. Chem. Soc. 126, 273 (2004).
9. S.H. Sun, H. Zeng, Size-controlled synthesis of magnetite nanoparticles, J. Am. Chem. Soc. 124, 8204 (2002).
10. Y.T. Lim, et al, Simultaneous intracellular delivery of targeting antibodies and functional nanoparticles with engineered protein g system, Biomaterials. 30, 1197 (2009).
11. W.S. Haubrich, Kupffer of Kupffer cells, Gastroenterol, 127(1), 16 (2004).
12. R. Szymanska, M. Schmidt-Pospuła, Studies of liver's reticuloendothelial cells by Tadeusz Browicz and Karl Kupffer, A historical outline, Arch. Hist. Med. 42(3), 331 (1979).
13. W. Bult, R. Arkevisser, F. Soulimani, Holmium Nanoparticles: Preparation and In Vitro Characterization of a New Device for Radioablation of Solid Malignancies, Pharm. Res. 27, 2205 (2010).
14. J.F.W. Nijsen, et al. Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: Effects of preparation and neutron activation techniques, Eur. J. Nucl. Med. 26, 699 (1999).
17. S. Jurisso, et al. Coordination compounds in Nuclear Medicine. Chem. Rev. 3, 1137 (1993).